Lancashire and South Cumbria
Formulary
Formulary
2 Cardiovascular system
02-11 Antifibrinolytic drugs and haemostatics
| Tranexamic Acid |
|
Formulary
|
| Injection 500mg/5mL |
 NICE NG39: Major trauma: assessment and initial management |
|
Links
BCSH Guidelines - heritable thrombophilia- Enoxaparin Shared Care Guideline **FOR USE IN THE MORECAMBE BAY REGION ONLY**
- Low Molecular Weight Heparins - Use in Primary care Best Practice Guideline *FOR USE IN PENNINE REGION ONLY*
- LSCMMG: Atrial Fibrillation
- LSCMMG: Heart Failure - Primary Care Guideline for the Use of SGLT-2 Inhibitors in Reduced Ejection Fraction Heart Failure
- LSCMMG: Lipid Management Pathway for Primary Prevention of Cardiovascular Disease
- LSCMMG: Lipid Management Pathway for Secondary Prevention of Cardiovascular Disease
- LSCMMG: Low Molecular Weight Heparins (LMWHs) Summary Prescribing Guide
- Manufacturers data sheet
- Manufacturers data sheet (SPC)
- MHRA withdrawal information
- MHRA: Clopidogrel and proton pump inhibitors: interaction—updated advice
- NG 185 - Acute coronary syndromes
- NG 196 - Atrial fibrillation: diagnosis and management
- NICE NG106: Chronic heart failure in adults: diagnosis and management
- NICE NG136: Hypertension in adults: diagnosis and management
- NICE NG187: Acute heart failure: diagnosis and management
- NICE NG203: Chronic kidney disease: assessment and management
- NICE NG39: Major trauma: assessment and initial management
- NICE NG95: Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis